<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: goldman</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'goldman'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22goldman%22&t=%22goldman%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:15:32 +0100</lastBuildDate>
        <item>
            <title>Should Psychiatrists Disclose Their Personal History To Patients?</title>
            <link>http://www.medworm.com/index.php?rid=5036236&amp;cid=t_275756_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fshould-psychiatrists-disclose-their-personal-history-to-patients%2F2011.07.16</link>
            <description>Dr. Maureen Goldman talks about self-disclosure for psychiatrists and brings the topic up in the context of Marsha Linehan&amp;#8217;s recent announcement that she was treated for a psychiatric disorder as a teenager.
In Clinical Psychiatry News, Dr. Goldman notes:
Psychiatric care and psychotherapy are different from the Alcoholics Anonymous fellowship, where the mutual sharing of personal experience is an integral part of helping people maintain sobriety. I believe that there is middle ground between disclosing personal information and presenting myself as a blank slate. In my practice, I show myself to be a real person. I make mistakes and admit them. I joke about my poor bookkeeping skills and inferior technological skills. I look things up during sessions if necessary, and I tell patients...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5036236</comments>
            <pubDate>Sat, 16 Jul 2011 12:00:00 +0100</pubDate>
            <guid isPermaLink="false">5036236</guid>        </item>
        <item>
            <title>Infant Mortality Rates Increase With Vaccines</title>
            <link>http://www.medworm.com/index.php?rid=4789254&amp;cid=t_275756_87_f&amp;fid=39261&amp;url=http%3A%2F%2Fvactruth.com%2F2011%2F05%2F05%2Finfant-mortality-rates-increase-with-vaccines%2F</link>
            <description>In the just published (May 4, 2011) online journal article, “Infant mortality rates regressed against number of vaccine doses routinely given: Is there a biochemical or synergistic toxicity?” in Human and Experimental Toxicology, authors Neil Z Miller and Gary S Goldman state:
“Nations that require more vaccine doses tend to have higher infant mortality rates.”
 
That statement is based upon a study of the infant mortality rate (IMR) in numerous nations that require infant vaccinations.  Although the authors agree that clean water, increased nutritional measures, better sanitation, and easy access to health care contribute the most to improving infant mortality rates, they found that vaccines were not a predominate factor in infant survival, but probably contribute to Sudden Infan...</description>
            <author>vactruth.com</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4789254</comments>
            <pubDate>Thu, 05 May 2011 16:46:44 +0100</pubDate>
            <guid isPermaLink="false">4789254</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=4704958&amp;cid=t_275756_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FhWBKw4PwEO0%2F</link>
            <description>Top of the morning to you. Gray skies are hovering over the Pharmalot corporate campus this morning, where we are hustling the short people off to the school house for some learning and quaffing our usual cup of stimulation - our flavor today is Mocha Fudge Nut. Please join us. While you do, here are some tidbits from around your universe. We hope your day is productive and rewarding. Meanwhile, let us know of anything interesting or unusual. Have a great one&amp;#8230;
Study Reveals New Target For Antidepressants (Reuters)
Teva MS Pill Reduces Relapses Less Most Injectables (Bloomberg News)
Glaxo Moving More Jobs To Scotland (Scotland Herald)
FDA Approves Merck Skin Cancer Drug (Reuters)
Biogen MS Pill Shows Promise In Study (Associated Press)
UK Docs May Consider Cost When Prescribing Off-La...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4704958</comments>
            <pubDate>Tue, 12 Apr 2011 12:07:42 +0100</pubDate>
            <guid isPermaLink="false">4704958</guid>        </item>
        <item>
            <title>What a Conflicted Web We Weave: Academic Economists, Finance, the Global Economic Meltdown, and the Impending Health Care Collapse</title>
            <link>http://www.medworm.com/index.php?rid=4036597&amp;cid=t_275756_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2010%2F10%2Fwhat-conflicted-web-we-weave-academic.html</link>
            <description>We have been writing about conflicts of interest in health care now for a long time.&amp;nbsp; We started with a focus on academic physicians' &amp;nbsp;and leaders' financial ties to pharmaceutical/ biotechnology/ device companies, then went on to the intense conflicts generated by academic medical and other health care non-profit leader&amp;nbsp;who also sit on boards of directors of for profit health care corporations,&amp;nbsp;and to conflicts affecting various kinds of respected not-for-profit health care organizations, like&amp;nbsp;medical societies and patient advocacy groups.Meanwhile, we&amp;nbsp;uncovered the curious dominance of the&amp;nbsp;boards of some health care organizations by leaders in the finance world, including some of the leaders of the failed companies that brought us the&amp;nbsp;&quot;great recess...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4036597</comments>
            <pubDate>Wed, 06 Oct 2010 20:11:00 +0100</pubDate>
            <guid isPermaLink="false">4036597</guid>        </item>
        <item>
            <title>‘Make Wall Street traders and CEOs fear for their lives, or at least for their freedom to travel.’</title>
            <link>http://www.medworm.com/index.php?rid=3629620&amp;cid=t_275756_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FhUEjTZCgBhw%2F</link>
            <description>By Walter OlsonRecall the unionists&amp;#8217; siege of the Maryland banker&amp;#8217;s home the other day? Perhaps it was inspired in part by this screed on the world financial crisis that appeared a little while back on the blog New Deal 2.0, published by the left-leaning Franklin and Eleanor Roosevelt Institute. Other advice in the same piece on how to handle execs from Goldman Sachs and similar investment banks: &amp;#8220;Build some Guantanamo-like facility to hold these enemy financial combatants until they can be tried, convicted, and properly punished.&amp;#8221; And: &amp;#8220;Post the names of all managers and traders on Interpol. Arrest anyone who tries to board a plane, train, or boat; confiscate their passports; revoke their visas and work permits; and put a hold on their bank accounts until cul...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3629620</comments>
            <pubDate>Thu, 03 Jun 2010 18:09:53 +0100</pubDate>
            <guid isPermaLink="false">3629620</guid>        </item>
        <item>
            <title>SEC Incompetence</title>
            <link>http://www.medworm.com/index.php?rid=3499049&amp;cid=t_275756_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2Fwa-L6rBh0XI%2F</link>
            <description>By Mark A. CalabriaThere has been much speculation that the Securities and Exchange Commission (SEC) released its charges against Goldman Sachs on the eve of a Senate vote on new finance regulation in order to help Democrats win that vote.  Perhaps that theory is wrong: It now looks more likely that the SEC timed its Goldman case in order to divert attention away from two SEC inspector general (IG) reports criticizing the commission.
In one of the reports, the SEC IG found that several of the top staffers at the SEC were spending their days surfing the web for porn, rather than looking for securities fraud.  One senior manager spent almost 8 hours a day looking a porn, getting to the point where he even filled up his government issued hard-drive with porn.  His actions were not ...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3499049</comments>
            <pubDate>Fri, 23 Apr 2010 16:09:52 +0100</pubDate>
            <guid isPermaLink="false">3499049</guid>        </item>
        <item>
            <title>SEC vs. Goldman Sachs: Legislation by Demonization</title>
            <link>http://www.medworm.com/index.php?rid=3494297&amp;cid=t_275756_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FspXUjt4XBzk%2F</link>
            <description>By Alan ReynoldsThe Obama administration thinks it has discovered the perfect formula to cram legislation through in a hurry:  Demonize some prominent firm within an industry you plan to redesign, and then pass a law that has nothing to do with the accusation against the demonized firm.  They did this with health insurance and now they’re trying it with finance.
With health insurance, the demon was Anthem Blue Cross Blue Shield of California, which Obama accused of raising premiums by “anywhere from 35 to 39 percent.” Why didn’t some curious reporter interview a single person who actually paid 39% more, or quote from a letter announcing such an increase?  Because it didn’t happen.  Insurance premiums are regulated by the states, and California wouldn’t approve such a boost....</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3494297</comments>
            <pubDate>Wed, 21 Apr 2010 19:46:01 +0100</pubDate>
            <guid isPermaLink="false">3494297</guid>        </item>
        <item>
            <title>Read It Like a Man: Books for Guys That Women Should Borrow</title>
            <link>http://www.medworm.com/index.php?rid=3432855&amp;cid=t_275756_87_f&amp;fid=36050&amp;url=http%3A%2F%2Fblisstree.com%2Flive%2Fread-it-like-a-man-books-for-guys-that-women-should-borrow%2F</link>
            <description>photo: Thinkstock
Chapter One: Baseball
Opening Day for Major League Baseball is April 5, which dovetails nicely with the beginning of this series. It’s also a good starting point because baseball has always induced the nostalgic sandlot memory-lane-strolls of aging white men like Doris Kearns Goodwin. And the season goes on for-freaking-ever, so you can knock all three books out of the park by the All-Star break (July).
The Natural by Bernard Malamud
The Stats: For all the ink spilled about America’s “national pastime” (the one the NFL usurped about 30 years ago), there are very few great baseball novels. The Natural is one of them. You’ve seen the movie; you know the story. A 19-year-old prodigy, Roy Hobbs, gets shot by a mystery woman, drops out of sight, then magically reappe...</description>
            <author>Breastfeeding 1-2-3</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3432855</comments>
            <pubDate>Thu, 01 Apr 2010 20:47:39 +0100</pubDate>
            <guid isPermaLink="false">3432855</guid>        </item>
        <item>
            <title>California Chronicle Book Review</title>
            <link>http://www.medworm.com/index.php?rid=3416284&amp;cid=t_275756_137_f&amp;fid=39091&amp;url=http%3A%2F%2Falzheimmers.blogspot.com%2F2010%2F02%2Fbook-pleasures-book-review.html</link>
            <description>Below is a link to Norm Goldman's review of When Can I Go Home? from California Chronicle website:http://www.californiachronicle.com/articles/view/141187 (Source: Caregiver Survival: I Hate Alzheimer's)</description>
            <author>Caregiver Survival: I Hate Alzheimer's</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3416284</comments>
            <pubDate>Sat, 20 Feb 2010 17:57:00 +0100</pubDate>
            <guid isPermaLink="false">3416284</guid>        </item>
        <item>
            <title>Goldman Sachs At Your Service</title>
            <link>http://www.medworm.com/index.php?rid=3280160&amp;cid=t_275756_136_f&amp;fid=37852&amp;url=http%3A%2F%2Fdonnatrussell.com%2F2010%2F02%2F17%2Fgoldman-sachs-at-your-service%2F</link>
            <description>New cartoon by Trussell &amp; Trussell on AOL’s Politics Daily. Goldman Sachs At Your Service.
Filed under: Politics Daily Tagged: bank, chaos theory, euro, goldman sachs, greece, political cartoon, wall street (Source: Donna Trussell)</description>
            <author>Donna Trussell</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3280160</comments>
            <pubDate>Wed, 17 Feb 2010 16:10:10 +0100</pubDate>
            <guid isPermaLink="false">3280160</guid>        </item>
        <item>
            <title>A University President, But No Longer a Goldman Sachs Director</title>
            <link>http://www.medworm.com/index.php?rid=3275761&amp;cid=t_275756_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2010%2F02%2Funiversity-president-but-no-longer.html</link>
            <description>A frequent topic on Health Care Renewal is how leaders of not-for-profit health care organizations now frequently value their &quot;margin,&quot; that is, revenue generation more than mission.&amp;nbsp; (One good example here shows how medical school leaders value faculty most for how much money they bring in, rather than the quality of their teaching, research, or patient care.)&amp;nbsp; &quot;Masters of the Universe&quot; as Leaders of Academic MedicineAs we have cast about for reasons behind this important and unfortunate transformation, we noticed that many of the members of the boards of trustees of some of the most prestigious universities that house medical schools, medical schools, and teaching hospitals seemed to be leaders in the finance industry. The importance of that finding became more relevant after t...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3275761</comments>
            <pubDate>Mon, 15 Feb 2010 22:48:00 +0100</pubDate>
            <guid isPermaLink="false">3275761</guid>        </item>
        <item>
            <title>Why Wall Street Loves Obama</title>
            <link>http://www.medworm.com/index.php?rid=2803895&amp;cid=t_275756_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FtlWqSujwMDA%2F</link>
            <description>Was it just me, or did there seem to be a whole lot of applause during Obama&amp;#8217;s Wall Street speech?  Remember this was a room full of Wall Street executives.  The President even started by thanking the Wall Street execs for their &amp;#8220;warm welcome.&amp;#8221;
While of course, there was the obligatory slap on the wrist, that &amp;#8220;we will not go back to the days of reckless behavior and unchecked excess,&amp;#8221; but there was no mention that the bailouts were a thing of the past.  Indeed, there is nothing in Obama&amp;#8217;s financial plan that would prevent future bailouts, which is why I believe there was such applause.  The message to the Goldman&amp;#8217;s of the world, was, you better behave, but even if you don&amp;#8217;t, you, and your debtholders will be bailed out.
The president also...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2803895</comments>
            <pubDate>Wed, 16 Sep 2009 18:21:46 +0100</pubDate>
            <guid isPermaLink="false">2803895</guid>        </item>
        <item>
            <title>Too Risky to Continue</title>
            <link>http://www.medworm.com/index.php?rid=2681878&amp;cid=t_275756_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FW9fhTflpsiE%2F</link>
            <description>The profits being reported so far this year by the major financial firms appear to be driven by proprietary trading (trading for their own account, as opposed to those of their customers). The recent $3.44 billion profit of Goldman Sachs in the second quarter is a dramatic case in point.
Proprietary trading is a high-risk activity and signals the financial sector is returning to its bad old ways. Returns cannot be systematically high unless risk is correspondingly high.
None of this would matter if it were just private capital at stake. But Goldman, along with other major financial firms, is being guaranteed under the dubious doctrine that it is too-big-to-fail. Better there were no government guarantees. As long as these guarantees are in place, however, high-risk activity must be curtail...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2681878</comments>
            <pubDate>Fri, 07 Aug 2009 13:37:33 +0100</pubDate>
            <guid isPermaLink="false">2681878</guid>        </item>
        <item>
            <title>Out of the TARP, But Still on the Dole</title>
            <link>http://www.medworm.com/index.php?rid=2653669&amp;cid=t_275756_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FgXFYSxav4ZQ%2F</link>
            <description>While banks such as Goldman and J.P. Morgan have managed to find a way to re-pay the capital injections made under the TARP bailout, their reliance on public subsidies is far from over. The federal government, via a debt guarantee program run by the FDIC, is still putting considerable taxpayer funds at risk on behalf of the banking industry.  The Wall Street Journal estimates that banks participating in the FDIC debt guarantee program will save about $24 billion in reduced borrowing costs of the next three years. The Journal estimates that Goldman alone will save over $2 billion on its borrowing costs due to the FDIC&amp;#8217;s guarantees.
One of the conditions imposed by the Treasury department for allowing banks to leave the TARP was that such banks be able to issue debt not guaranteed...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2653669</comments>
            <pubDate>Wed, 29 Jul 2009 18:48:54 +0100</pubDate>
            <guid isPermaLink="false">2653669</guid>        </item>
        <item>
            <title>Improving the world, and one's brain, at the same time</title>
            <link>http://www.medworm.com/index.php?rid=2353955&amp;cid=t_275756_122_f&amp;fid=36582&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FSharpBrains%2F%7E3%2Fz-myvW1TxG4%2F</link>
            <description>My wife and I just came back from an inspiring Goldman Prize Award ceremony, where seven grassroots environmental changemakers were recognized for their work and resiliency, and shared their passion and purpose with everyone attending the event. We did hear too from Al Gore, Tracy Chapman, Robert Redford, and the founder of the awards 20 years ago, Richard Goldman. 
The BBC recently published an Op-Ed by Mr. Goldman on the story behind the Awards themselves: article Here. He explains how...


- &amp;quot;One morning in 1989, as I sat with my daily breakfast and newspaper, I read about the most recent Nobel laureates and wondered if there was a comparable award for environmental work.&amp;quot;


- &amp;quot;We asked a staff member at our foundation to do some research and he found that nothing yet e...</description>
            <author>SharpBrains</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2353955</comments>
            <pubDate>Tue, 21 Apr 2009 04:27:08 +0100</pubDate>
            <guid isPermaLink="false">2353955</guid>        </item>
        <item>
            <title>Goldman Sachs Plans New Funding For Research</title>
            <link>http://www.medworm.com/index.php?rid=2011556&amp;cid=t_275756_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F473540110%2F</link>
            <description>Goldman Sachs is in talks to provide hundreds of millions of dollars of funding to a large drugmaker, in what appears to be an attempt to create a new business model that will see financing shifting towards co-development of specific meds, The Financial Times reports.
Jon Symonds, managing director at the investment bank in London and former finance director at AstraZeneca, says a first deal to create a new hybrid model of R&amp;#038;D should be finalized early next year and reflected the desire for even large drugmakers with strong sales on existing drugs to seek funding for future development, according to the FT.
The Goldman Sachs model would form a &amp;#8220;research pool&amp;#8221; into which drugmakers would place a range of experimental drugs in a single therapeutic area in early-stage phase 1...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2011556</comments>
            <pubDate>Wed, 03 Dec 2008 12:08:07 +0100</pubDate>
            <guid isPermaLink="false">2011556</guid>        </item>
        <item>
            <title>Pfizer Downgraded As Wall Street Loses Confidence</title>
            <link>http://www.medworm.com/index.php?rid=1497751&amp;cid=t_275756_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F305364686%2F</link>
            <description>Here&amp;#8217;s some more pressure on ceo Jeff Kindler and his new cfo, Frank D&amp;#8217;Amelio. Goldman Sachs, one of the Street&amp;#8217;s biggest firms, downgraded Pfizer stock and removed the drugmaker from its &amp;#8220;Americas conviction&amp;#8221; list, citing the stock&amp;#8217;s under performance and a lack of near-term events to boost the value of the shares.
The brokerage cut its rating to &amp;#8220;neutral&amp;#8221; from &amp;#8220;buy,&amp;#8221; noting that Pfizer&amp;#8217;s share price has fallen 28.7 percent since Jan. 4, 2007, versus a 2.9 percent decline in the Standard &amp;#038; Poor&amp;#8217;s 500 Index SPX, Reuters reports.
Goldman further cut its price target on Pfizer to $22 from $26 as near-term pipeline products decrease in value and recent safety issues pressure the brokerage&amp;#8217;s forecasts for the dr...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1497751</comments>
            <pubDate>Thu, 05 Jun 2008 14:31:04 +0100</pubDate>
            <guid isPermaLink="false">1497751</guid>        </item>
        <item>
            <title>What FDA Safety Rule? Steve Goldman Explains</title>
            <link>http://www.medworm.com/index.php?rid=996640&amp;cid=t_275756_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F178165088%2F</link>
            <description>The FDA Amendments Act may have just been enacted, but that doesn’t mean all safety issues have been resolved. Depending upon who you speak with about the agency, you can hear lingering concerns and complaints about unfinished business. One such issue is a proposed rule on safety reporting requirements for drugs and biologics, which was released by the FDA for comment in 2003. Designed to update industry pre-and postmarketing safety reporting requirements, the proposed rule has languished with no announced timetable for finalization and implementation.
We chatted by phone and e-mail with Stephen Goldman, a physicians and former FDA MedWatch Medical Director who is now an independent industry consultant. While at the agency, he participated in drafting the 2003 proposed rule, and recently...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=996640</comments>
            <pubDate>Thu, 01 Nov 2007 10:40:42 +0100</pubDate>
            <guid isPermaLink="false">996640</guid>        </item>
        <item>
            <title>Former Pfizer Worker Faces Charges Over Data Breach That Affected 34,000 People</title>
            <link>http://www.medworm.com/index.php?rid=903797&amp;cid=t_275756_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F161064834%2F</link>
            <description>The drugmaker has contacted federal authorities in hopes they will prosecute a former employee responsible for a data breach that affected 34,000 people, according to info released by the Connecticut attorney general, The Day reports. This was one of three episodes involving Pfizer data breaches this year; the first one affected 17,000 former and current employees.
Pfizer attorney Bernard Nash, in a five-page response to questions posed earlier this month by state Attorney General Richard Blumenthal, said the drugmaker contacted “a management-level federal prosecutor” and now hopes the former employee will be prosecuted “to the fullest extent of the law.” In his Sept. 12 letter, Nash writes that Pfizer learned of the data breach after the suspect had left the drugmaker. The suspect...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=903797</comments>
            <pubDate>Tue, 25 Sep 2007 12:57:12 +0100</pubDate>
            <guid isPermaLink="false">903797</guid>        </item>
        <item>
            <title>We Must Be Stupid, Stupid, Stupid: Mega Life and Health</title>
            <link>http://www.medworm.com/index.php?rid=773302&amp;cid=t_275756_117_f&amp;fid=34612&amp;url=http%3A%2F%2Fwww.thedoctorweighsin.com%2Fjournal%2F2007%2F8%2F1%2Fwe-must-be-stupid-stupid-stupid-mega-life-and-health.html</link>
            <description>Brian KlepperI&amp;rsquo;ve filled a lot of airtime and column inches over the last couple years talking about the financial conflicts that characterize so much of health care. I&amp;rsquo;ve focused on topics like oncology drug rebates, Medicare D drug plan scams and unnecessary care by doctors and hospitals, but the truth is that these unethical and abusive practices abound in virtually every area of health care. These outrages are often glossed over because they&amp;rsquo;re perpetrated by respectable people presumably working under the mantle of a higher mission. Of course many health care professionals are mortified by these practices and know that the system must change. I recently did a video commentary on financially conflicted care on Medscape and expected a physician backlash. What arrived i...</description>
            <author>The Doctor Weighs In</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=773302</comments>
            <pubDate>Wed, 01 Aug 2007 11:06:44 +0100</pubDate>
            <guid isPermaLink="false">773302</guid>        </item>
    </channel>
</rss>

